FARALLON CAPITAL MANAGEMENT LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$641,403
-9.7%
21,7720.0%0.00%
-25.0%
Q2 2023$710,203
-97.8%
21,772
-97.7%
0.00%
-97.8%
Q1 2023$33,010,754
-57.7%
938,072
-44.9%
0.18%
-60.6%
Q4 2022$77,973,635
-0.7%
1,701,738
+5.0%
0.46%
+7.1%
Q3 2022$78,539,000
-11.0%
1,621,038
-27.8%
0.43%
-9.8%
Q2 2022$88,208,000
+27.3%
2,245,038
+19.3%
0.48%
+44.0%
Q1 2022$69,298,000
-29.9%
1,882,599
-13.3%
0.33%
-32.4%
Q4 2021$98,924,000
+1.3%
2,170,342
-20.6%
0.49%
+8.3%
Q3 2021$97,669,000
+71.6%
2,732,775
-5.0%
0.46%
+96.6%
Q2 2021$56,916,000
-2.1%
2,876,000
+15.0%
0.23%
-19.7%
Q1 2021$58,150,000
+16.6%
2,500,000
+4.2%
0.29%
-3.7%
Q4 2020$49,872,000
+7.1%
2,400,000
+11.6%
0.30%
-6.8%
Q3 2020$46,548,000
+31.7%
2,150,000
+43.3%
0.32%
+13.8%
Q2 2020$35,355,000
+379.8%
1,500,000
+140.0%
0.28%
+349.2%
Q1 2020$7,369,000625,0000.06%
Other shareholders
CYTOKINETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders